Charles Maroney has been president/CEO, since February 2006, of CardioMind (Sunnyvale, California), a development-stage company focused on a small-diameter stent delivery platform with applications in treating coronary, neuro and peripheral artery disease. This is currently a $5 billion-plus worldwide market.
Browse by Speciality Area